STEM-PD Parkinson’s Trial: 12-Month Safety Data Published in Nature
Are you tired of Parkinson’s disease treatments that only mask symptoms while the condition continues to progress? Many patients and families share this frustration, wondering if a true disease-modifying therapy will ever arrive. The recent publication of the STEM-PD Parkinson’s trial results in Nature offers a strong reason for hope. This phase 1/2 trial evaluated […]
Kenai Therapeutics Completes Phase 1b/2a Trial Enrollment for Parkinson’s Cell Therapy
Are you or a loved one watching Parkinson’s disease slowly take away independence and motor control? It is a heavy burden, and current treatments often feel like putting a small bandage on a deep wound. They manage the symptoms but do nothing to stop the disease from progressing or repair the damage already done. This […]
Off-the-Shelf Stem Cell Therapy for Parkinson’s Cleared for US Trials
The FDA has cleared US clinical trials for UX-DA003, an off-the-shelf stem cell therapy for Parkinson’s disease. Learn how this allogeneic treatment works.
Stem-Cell-Derived Dopamine Neurons and Parkinson’s: UCLA’s $9M Environmental Risk Study
UCLA will use stem-cell-derived dopamine neurons to study how pesticides and pollution may affect Parkinson’s risk.
World-First: Japan Approves Stem Cell Therapy for Parkinson’s
In a historic move, Japan has become the first country to approve a stem cell therapy for Parkinson’s disease, a major milestone that experts are watching with cautious optimism. On March 17, 2026, Japan’s regulatory agency granted conditional approval to Ampchepry, a new therapy developed by Sumitomo Pharma and Ratchera. This makes it the first […]
Brain Cell Implants: A New Hope for Parkinson’s Patients?
A groundbreaking clinical trial is testing whether stem cell implants can restore brain function in people with Parkinson’s disease, offering a potential new path to slow the disease and improve quality of life. For the more than one million people in the United States living with Parkinson’s disease, treatment options have been limited to managing […]
Stem Cell Therapy for Parkinson’s Disease: Breakthrough Clinical Trials Offer New Hope
Will stem cell therapy finally offer a cure for Parkinson’s disease? Can lost brain cells truly be replaced? These are the questions that millions of patients and families ask as they search for better treatment options. Recent clinical trials have brought us closer to answering these questions. Leading experts Dr. Jun Takahashi and Dr. Claire […]
Aspen Neuroscience’s Personalized Parkinson’s Therapy Shows Promise in Clinical Trial
For the millions of people living with Parkinson’s disease, the search for effective treatments is a constant source of hope and concern. Current therapies manage symptoms but do not stop the progression of the disease. However, recent advancements in cell therapy are offering a new frontier in the fight against Parkinson’s. A New Era for […]
Kenai Therapeutics Gets $8M Boost for Parkinson’s Treatment
A New Hope for Parkinson’s Patients Kenai Therapeutics, a San Diego-based biotechnology company, has received an $8 million grant from the California Institute for Regenerative Medicine (CIRM). This funding will help advance their lead program, RNDP-001, a promising new treatment for idiopathic Parkinson’s disease. The grant was awarded to Dr. Howard J. Federoff, the company’s […]
Parkinson’s Symptoms Reversed: A Stem Cell Breakthrough?
For the 10 million people worldwide living with Parkinson’s disease, the daily battle with tremors, stiffness, and loss of motor control is a constant reality. But a groundbreaking clinical trial in China has delivered a powerful new sense of hope, as a 37-year-old woman has achieved a “functional cure” just three months after receiving a […]